Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9188526 | Clinical Neurophysiology | 2005 | 6 Pages |
Abstract
Parkinsonian patients with peak-dose dyskinesias are not bradykinetic, probably because dopamine at peak doses functionally normalizes the mechanisms controlling movement speed.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
R. Agostino, S. Bagnato, L. Dinapoli, N. Modugno, A. Berardelli,